Helvetica Capital, based in Zürich, is a venture capital fund targeting early-stage investments primarily in biotech, manufacturing, and health tech sectors. They typically provide seed funding, with notable investments including Microcaps. The fund focuses on supporting Swiss companies to foster local innovation and development.
